Integrium
Founded in 1998 by visionary clinical research thought leaders, Integrium is a full-service Clinical Proof of Concept (PoC) firm that specializes in a wide range of therapeutic areas including cardiovascular, metabolic disease and dermatology research.
We play a key role in furthering new medical advancements by helping pharmaceutical companies design and execute clinical studies, ensuring they achieve their objectives on time, on budget, and with expected quality.
With cutting-edge technology and unparalleled services
Tustin, CA – Integrium, LLC Executives will be in Boston during the Oncology Investor Conference on March 14th through 15th. This oncology investor conference is sponsored by National Foundation for Cancer Research, OneMedMarket, and McDermott Will & Emery, among others.
Integrium
Integrium
Integrium